EXICURE, INC. Shares Outstanding (Cover Page)
EXICURE, INC. (XCUR) had Shares Outstanding (Cover Page) of 6.55 million shares as of 2026-08-13, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-13: Entity Common Stock, Shares Outstanding 6.55M shares.
- 2026-05-26: Entity Common Stock, Shares Outstanding 6.37M shares.
- 2026-03-17: Entity Common Stock, Shares Outstanding 6.37M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 6.37M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 6.55M shares 10-Q · filed 2026-08-14 |
| 2026-05-26 | 6.37M shares 10-Q · filed 2026-05-29 |
| 2026-03-17 | 6.37M shares 10-K · filed 2026-03-25 |
| 2025-11-03 | 6.37M shares 10-Q · filed 2025-11-07 |
| 2025-08-05 | 6.32M shares 10-Q · filed 2025-08-08 |
| 2025-06-23 | 6.32M shares 10-Q · filed 2025-06-27 |
| 2025-03-12 | 6.32M shares 10-K · filed 2025-03-18 |
| 2024-11-07 | 2.17M shares 10-Q · filed 2024-11-14 |
| 2024-08-06 | 8.65M shares 10-Q · filed 2024-08-13 |
| 2024-06-10 | 8.65M shares 10-Q · filed 2024-06-17 |
| 2024-05-31 | 8.65M shares 10-K · filed 2024-06-06 |
| 2024-05-13 | 8.65M shares 10-Q · filed 2024-05-16 |
| 2023-08-09 | 8.65M shares 10-Q/A · filed 2024-06-06 |
| 2023-07-10 | 8.65M shares 10-Q/A · filed 2024-06-06 |
| 2023-03-23 | 8.37M shares 10-K/A · filed 2023-05-01 |
| 2022-11-11 | 4.96M shares 10-Q · filed 2022-11-14 |
| 2022-08-11 | 4.96M shares 10-Q · filed 2022-08-15 |
| 2022-05-12 | 122.81M shares 10-Q · filed 2022-05-16 |
| 2022-03-23 | 122.79M shares 10-K · filed 2022-03-25 |
| 2021-11-12 | 88.12M shares 10-Q · filed 2021-11-19 |
| 2021-08-09 | 88.11M shares 10-Q · filed 2021-08-12 |
| 2021-05-10 | 87.99M shares 10-Q · filed 2021-05-12 |
| 2021-03-05 | 87.96M shares 10-K · filed 2021-03-11 |
| 2020-11-10 | 87.23M shares 10-Q · filed 2020-11-12 |
| 2020-08-10 | 87.23M shares 10-Q · filed 2020-08-12 |
| 2020-05-12 | 87.15M shares 10-Q · filed 2020-05-14 |
| 2020-03-05 | 87.15M shares 10-K · filed 2020-03-10 |
| 2019-11-05 | 75.99M shares 10-Q · filed 2019-11-07 |
| 2019-08-06 | 75.99M shares 10-Q · filed 2019-08-08 |
| 2019-05-06 | 44.37M shares 10-Q · filed 2019-05-08 |
| 2019-03-05 | 44.36M shares 10-K/A · filed 2019-09-23 |
| 2018-10-31 | 44.36M shares 10-Q · filed 2018-11-06 |
| 2018-07-31 | 39.45M shares 10-Q · filed 2018-08-06 |
| 2018-04-30 | 39.45M shares 10-Q · filed 2018-05-15 |
| 2018-02-28 | 39.45M shares 10-K · filed 2018-03-09 |
| 2017-11-13 | 39.30M shares 10-Q · filed 2017-11-14 |
| 2017-09-11 | 1.25M shares 10-Q · filed 2017-09-12 |
| 2017-07-10 | 1.25M shares 10-Q · filed 2017-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |